This move is archived. Current quotes and coverage live on the stock page.
Follow CURA
Curaleaf's stock saw a notable increase, driven by strategic maneuvers in the cannabis market.
Curaleaf Holdings Inc. (CURA.TO) experienced a robust gain of 3.54% in yesterday's trading session, closing at CA$13.45. This uptick comes amid significant developments in the cannabis sector, particularly regarding Curaleaf's aggressive bid for Aurora Cannabis.
Advertisement
Curaleaf Holdings Inc.
CURA.TO
CURA.TO
Curaleaf Holdings Inc.
WealthAwesomeMarket cap
$3.88B
52W high
$20.93
52W low
$7.77
1W change
-8.49%
Beta
1.64
Analyst Price Targets
Based on analyst covering CURA · as of Oct 2, 2026
Wall Street analysts forecast CURA stock price to rise 28.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.88
+28.8% Upside
Previously C$18.93 on Oct 1, 2026
Current Price
C$14.66
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CURA's historical volatility
30-Day Vol
54.2%
Annualized
90-Day Vol
60.9%
Annualized
Trend (90d)
+37.4%
Annualized drift
90d Mean
C$16.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$15.33 | C$12.71 – C$18.48 |
| 60 trading days | C$16.03 | C$12.30 – C$20.88 |
| 90 trading days | C$16.76 | C$12.12 – C$23.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of Curaleaf's acquisition strategy as it seeks to expand its footprint in the international medical cannabis market.
Curaleaf's market cap now stands at CA$3.56 billion.
With a market cap of CA$3.56 billion, Curaleaf is positioning itself as a formidable player in the cannabis industry, especially with its focus on medical cannabis expansion.
Bull case
Curaleaf's bid to take over Aurora Cannabis could strengthen its market position, especially in Europe, where Aurora has established operations. This move may attract investor interest as it shows potential for growth.
Bear case
However, there are risks involved. The uncertainty surrounding the acquisition process could pose challenges. If Curaleaf doesn’t secure Aurora, it might struggle to maintain its current momentum and investor confidence.
Advertisement
Curaleaf's Strategic Move
Curaleaf's stock performance yesterday was significantly influenced by its hostile takeover bid for Aurora Cannabis. By offering a premium to Aurora shareholders, Curaleaf aims to secure a foothold in the lucrative medical cannabis market, particularly in Europe. This aggressive strategy not only reflects Curaleaf's ambition but also its commitment to expanding its international presence.
Market Reactions and Future Outlook
The market responded positively to Curaleaf's bid, as evidenced by the stock's increase. Investors are keenly watching how the situation unfolds, especially given the potential for a counter-offer from other interested parties. However, the uncertainty surrounding the acquisition raises questions about the sustainability of this momentum if the deal does not materialize.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
